BMO Capital Maintains Outperform Rating on SAP Sees Growth Potential After Sapphire 2026 Tui Faces Scrutiny After E ColiLinked Death of Baby at Egyptian Resort Fed Rate Hike Expectations Resurface as Inflation Data Surges Traders Price in Potential December Increase HighYield Savings Account Rates Top 41 APY as of May 23 2026 Fuel Price Hikes Cloud Indias Demand Outlook as Product Growth Forecast Slashed 40 Japan and Philippines to Begin Formal Talks on IntelligenceSharing Agreement CARE Q1 2026 Earnings Major EPS Disappointment Belies Surprising Stock Stability EVGO Q1 2026 Earnings Narrower Loss Surpasses Analyst Expectations Amidst Operational Gains XXII Q1 2026 Earnings Significant EPS Miss Highlights Continued Challenges BriaCell Therapeutics Q1 2026 Earnings NarrowerthanExpected EPS Loss Despite No Revenue BingEx FLX Q1 2026 Earnings Net Loss Reported Amid Limited Disclosure WAVE Q1 2026 Earnings Strong EPS Beat Amid No Revenue Stock Declines Blackrock MuniYield New York Quality Fund MYN Edges Higher Approaching 10 Resistance Qualys Stock Declines 39 as Cybersecurity Sector Faces Headwinds Westlake Chemical Partners WLKP Holds Steady Near 225 Amid Narrow Trading Range Jack In The Box JACK Surges Nearly 10 as Reversal Momentum Builds Kazia Therapeutics KZIA Faces Sharp Decline as Biotech Volatility Resurfaces Satellos Bioscience Inc MSLE Q1 2026 Earnings EPS Beat with 1358 Surprise Stock Declines 546 Ascent Industries Co ACNT Q1 2025 Earnings Losses Widen as EPS Misses Estimates Sharply Beyond Air Inc XAIR Q1 2026 Earnings Narrowing Loss Beats Street Expectations SLSN Q1 2026 Earnings Slim Loss Provides Silver Lining Despite Opaque Revenue Picture CRDF Q1 2026 Earnings WiderthanExpected Loss Reflects Ongoing RD Investments CPIX Q1 2026 Earnings Narrowing Losses and Strategic Progress Amidst Revenue Challenges SpaceX Files for Stock Market Debut Under Ticker SPCX Potentially Elevating Elon Musk to Trillionaire Status Crane Company CR Q1 2026 Earnings Strong Earnings Beat Driven by Operational Excellence Pliant Therapeutics PLRX Holds Near Support Amid Modest Gains Key Levels in Focus